Products in the Pipeline

Our pipeline consists of potentially first-in-class products with unique benefits to serve patient needs.

Cevira® for the treatment of HPV and precancerous lesions of the cervix. Ready to enter into the Phase 3 clinical program.

Visonac® for the treatment of inflammatory acne. Ready to enter into the Phase 3 clinical program.